help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ensinck, J. W.
Right arrow Articles by D’Alessio, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ensinck, J. W.
Right arrow Articles by D’Alessio, D. A.
Endocrinology Vol. 143, No. 7 2599-2609
Copyright © 2002 by The Endocrine Society


GRH-SOMATOSTATIN-GH

Thrittene, Homologous with Somatostatin-28(1–13), Is a Novel Peptide in Mammalian Gut and Circulation

John W. Ensinck, Denis G. Baskin, Torsten P. Vahl, Robin E. Vogel, Ellen C. Laschansky, Bruce H. Francis1, Ross C. Hoffman2, Jonathan D. Krakover3, Michael R. Stamm, Malcolm J. Low, Marcelo Rubinstein4, Veronica Otero-Corchon and David A. D’Alessio

Division of Metabolism, Endocrinology, and Nutrition, Department of Medicine (J.W.E., D.G.B., R.E.V., E.C.L., B.H.F.) and Department of Biological Structure (D.G.B.), University of Washington, Seattle, Washington 98195; Department of Veterans Affairs Puget Sound Health Care System (D.G.B.), Seattle, Washington 98108; ZymoGenetics (R.C.H., J.D.K., M.R.S.), Seattle, Washington 98102; Vollum Institute (M.J.L., M.R., V.O.-C.), Oregon Health Sciences University, Portland Oregon 97201-3098; and Division of Endocrinology (T.P.V., D.A.D.), University of Cincinnati, Ohio 45267-0547

Address all correspondence and requests for reprints to: David D’Alessio, M.D., University of Cincinnati, Division of Endocrinology, ML 0547, Cincinnati, Ohio 45267-0547. E-mail: . david.d'alessio{at}uc.edu

Preprosomatostatin is a gene expressed ubiquitously among vertebrates, and at least two duplications of this gene have occurred during evolution. Somatostatin-28 (S-28) and somatostatin-14 (S-14), C-terminal products of prosomatostatin (ProS), are differentially expressed in mammalian neurons, D cells, and enterocytes. One pathway for the generation of S-14 entails the excision of Arg13-Lys14 in S-28, leading to equivalent amounts of S-28(1–12). Using an antiserum (F-4), directed to the N-terminal region of S-28 that does not react with S-28(1–12), we detected a peptide, in addition to S-28 and ProS, that was present in human plasma and in the intestinal tract of rats and monkeys. This F-4 reacting peptide was purified from monkey ileum; and its amino acid sequence, molecular mass, and chromatographic characteristics conformed to those of S-28(1–13), a peptide not described heretofore. When extracts of the small intestine were measured by RIA, there was a discordance in the ratio of peptides reacting with F-4 and those containing the C terminus of ProS, suggesting sites of synthesis for S-28(1–13) distinct from those for S-14 and S-28. This was supported by immunocytochemistry, wherein F-4 reactivity was localized in gastrointestinal (GI) endocrine cells and a widespread plexus of neurons within the wall of the distal gut while immunoreactivity to C-terminal domains of S-14 and S-28 in these neurons was absent. Further, F-4 immunoreactivity persisted in similar GI endocrine cells and myenteric neurons in mice with a targeted deletion of the preprosomatostatin gene. We believe that these data suggest a novel peptide produced in the mammalian gut, homologous with the 13 residues of the proximal region of S-28 but not derived from the ProS gene. Pending characterization of the gene from which this peptide is derived, its distribution, and function, we have designated this peptide as thrittene. Its localization in both GI endocrine cells and gut neurons suggests that thrittene may function as both a hormone and neurotransmitter.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
J. W. Ensinck, E. C. Laschansky, R. E. Vogel, and D. A. D'Alessio
Effect of Ingested Nutrients on the Release of Thrittene into the Human Circulation
J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4798 - 4804.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Yaekura, R. Julyan, B. L. Wicksteed, L. B. Hays, C. Alarcon, S. Sommers, V. Poitout, D. G. Baskin, Y. Wang, L. H. Philipson, et al.
Insulin Secretory Deficiency and Glucose Intolerance in Rab3A Null Mice
J. Biol. Chem., March 7, 2003; 278(11): 9715 - 9721.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2002 by The Endocrine Society